Bayer stock pre-market at EUR 47.71: minus 0.13 percent
Published on 10/01/2026 at 08:03 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Bayer stock was at EUR 47.71 in pre-market trading at 8:01 a.m. CEST on October 1, 2026, down 0.13 percent versus the Lang & Schwarz prior close of EUR 47.77 on September 30, 2026.
Pre-market trading
The bid was EUR 47.61 and the ask was EUR 47.81 at Lang & Schwarz. The further course from the Xetra open at 9:00 a.m. CEST is shown by the continuously updated real-time quote of Bayer stock.
Recent Bayer developments
Bayer’s investor-news page lists a September 24, 2026 announcement that the U.S. Food and Drug Administration approved finerenone for a new indication in adults with chronic kidney disease associated with type 1 diabetes. The same page also lists FDA accelerated approval for Bayer’s sevabertinib as a first-line treatment option for adults with HER2-mutant non-small cell lung cancer. Bayer published both items in its investor-news section.
The company’s investor-news page also lists a September 2, 2026 update on its combined seed and crop protection pipeline. Bayer said commercialization of two blockbusters had already started, with additional launches expected over the following years. Bayer
